Literature DB >> 10844091

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

.   

Abstract

Entities:  

Year:  2000        PMID： 10844091     DOI： 10.1016/s0002-9394(00)00453-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  6 in total

1.  A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

Authors:  David E Arterburn; Andy Bogart; Nancy E Sherwood; Stephen Sidney; Karen J Coleman; Sebastien Haneuse; Patrick J O'Connor; Mary Kay Theis; Guilherme M Campos; David McCulloch; Joe Selby
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

2.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06

Review 3.  A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus.

Authors:  Rachel M Perrin; Steven J Harper; David O Bates
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

4.  Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults.

Authors:  David Arterburn; Andy Bogart; Karen J Coleman; Sebastien Haneuse; Joe V Selby; Nancy E Sherwood; Stephen Sidney; Mary Kay Theis; Guilherme M Campos; David McCulloch; Patrick J O' Connor
Journal:  Obes Res Clin Pract       Date:  2013 Jul-Aug       Impact factor: 2.288

5.  Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol.

Authors:  Sandrine Lablanche; Sandra David-Tchouda; Jennifer Margier; Edith Schir; Anne Wojtusciszyn; Sophie Borot; Laurence Kessler; Emmanuel Morelon; Charles Thivolet; François Pattou; Marie Christine Vantyghem; Thierry Berney; Pierre-Yves Benhamou
Journal:  BMJ Open       Date:  2017-02-20       Impact factor: 2.692

6.  Parp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation.

Authors:  Nyembezi Dhliwayo; Michael P Sarras; Ernest Luczkowski; Samantha M Mason; Robert V Intine
Journal:  Diabetes       Date:  2014-04-10       Impact factor: 9.461
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.